Company Filing History:
Years Active: 2021
Title: Tomomi Kawakatsu: Innovator in Antibody Development
Introduction
Tomomi Kawakatsu is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Kawakatsu's latest patents focus on the Anti-EphA4 antibody. This innovative antibody is designed to bind to EphA4 and enhance its cleavage. The patent details the creation of a mouse anti-EphA4 antibody that exhibits a strong binding affinity towards EphA4. The sequence of the complementarity-determining region (CDR) of this mouse antibody was identified, leading to the production of a humanized version of the antibody. This humanized anti-EphA4 antibody is expected to play a crucial role in pharmaceutical compositions aimed at treating diseases related to EphA4.
Career Highlights
Kawakatsu is currently employed at Eisai R&D Management Co., Ltd., where she continues to advance her research in antibody development. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.
Collaborations
Some of her notable coworkers include Eiji Inoue and Akio Yamada, who contribute to her research endeavors and collaborative projects.
Conclusion
Tomomi Kawakatsu is a trailblazer in the field of antibody research, with her innovative work on the Anti-EphA4 antibody paving the way for future advancements in medical treatments. Her contributions are invaluable to the scientific community and hold promise for improving patient outcomes.